Angene Chemical
Draw
|
Currency :
Home Products

AG003O6M

41859-67-0 | Bezafibrate

Chemical structure of Bezafibrate, CAS 41859-67-0
AG003O6M
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 41859-67-0
Catalog Number AG003O6M(AGN-PC-07A1RK)
Chemical Name Bezafibrate
EC Number 255-567-9
IUPAC Name 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid
InChI InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)
InChI Key IIBYAHWJQTYFKB-UHFFFAOYSA-N
MDL Number MFCD00078970
Molecular Formula C19H20ClNO4
Molecular Weight 361.8194
NSC Number 758174
SMILES CC(C)(OC1=CC=C(CCNC(C2=CC=C(Cl)C=C2)=O)C=C1)C(O)=O
UNII Y9449Q51XH
Synonyms
Azufibrat, Béfizal, Befibrat, Beza Lande, Beza Puren, Beza-Lande, Beza-Puren, Bezabeta, Bezacur, Bezafibrat PB, Bezafibrate, Bezafisal, Bezalip, Bezamerck, BM 15.075, BM-15.075, BM15.075, Cedur, Difaterol, durabezur, Eulitop, Lipox, Reducterol, Regadrin B, Sklerofibrat, Solibay, bezafibrate, 41859-67-0, Bezalip, Cedur, Bezafibrat, Befizal, Bezafibrato, Bezafibratum, Sklerofibrat, Azufibrat, Bezatol, Difaterol, Bezafibratum [INN-Latin], Bezafibrato [INN-Spanish], Bezafibrato [Spanish], Bezalip Retard, Bezatol SR (TN), BM 15075, LO 44, BM-15.075, BF-759, UNII-Y9449Q51XH, CCRIS 9085, BM 15.075, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid, EINECS 255-567-9, 2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid, BRN 4267656, C19H20ClNO4, MLS000028533, CHEMBL264374, durabezur, Reducterol, Bezabeta, Bezacur, Bezamerck, Eulitop, Solibay, CHEBI:47612, Lipox, IIBYAHWJQTYFKB-UHFFFAOYSA-N, 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]-2-methylpropanoic acid, Bezafibrat PB, Y9449Q51XH, Beza-Lande, Beza-Puren, Regadrin B, Propanoic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-, Propanoic acid, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-, MFCD00078970, NCGC00016850-01, SMR000058298, CAS-41859-67-0, DSSTox_CID_9869, BM-15075, Propionic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-, DSSTox_RID_78826, DSSTox_GSID_29869, W-106291, 2-(4-(2-(4-Chlorobenzamido)ethyl)phenoxy)-2-methylpropanoic acid, 2-(4-{2-[(4-chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid, 2-(4-{2-[(4-chlorophenyl)formamido]ethyl}phenoxy)-2-methylpropanoic acid, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-propanoic acid, 2-[P-[2-P-CHLOROBENZAMIDO)ETHYL]PHENOXY]-2-METHYLPROPIONIC ACID, Bezatol SR, SR-01000000106, Bezafibrate [USAN:BAN:INN:JAN], 2-{4-[2-(4-chlorobenzamido)ethyl]phenoxy}-2-methylpropanoic acid, Bezalip SR, Bezafibrate,(S), Bezafibrate [USAN:INN:BAN:JAN], PEM, Prestwick_724, BENAFIBRATE, PubChem4066, Spectrum_001443, Opera_ID_376, Prestwick0_000378, Prestwick1_000378, Prestwick2_000378, Prestwick3_000378, Spectrum2_000922, Spectrum3_001500, Spectrum4_000325, Spectrum5_001079, Spectrum5_001967, AC1L20XS, AC1Q5E4V, SCHEMBL16299, BSPBio_000535, BSPBio_001314, BSPBio_003119, KBioGR_000034, KBioGR_000669, KBioSS_000034, KBioSS_001923, MLS001148205, Bezafibrate, >=98%, solid, DivK1c_000092, SPECTRUM1502046, SPBio_000824, SPBio_002456, BPBio1_000589, GTPL2668, a-[4-(4-chlorobenzoylaminoethyl)phenoxy]isobutyric acid, DTXSID3029869, BDBM28701, Bezafibrate (JP17/USAN/INN), CTK8B3343, HMS500E14, KBio1_000092, KBio2_000034, KBio2_001923, KBio2_002602, KBio2_004491, KBio2_005170, KBio2_007059, KBio3_000067, KBio3_000068, KBio3_002619, 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]isobutyric Acid, NINDS_000092, Bio2_000034, Bio2_000514, HMS1361B16, HMS1569K17, HMS1791B16, HMS1921H16, HMS1989B16, HMS2089F04, HMS2092B12, HMS2096K17, HMS2233E22, HMS3261D21, HMS3369B13, HMS3402B16, HMS3650K22, HMS3652M22, HMS3713K17, Pharmakon1600-01502046, BCP03700, HY-B0637, ZINC3956919, Tox21_110645, Tox21_301845, Tox21_500500, 2-[4-(2-[4-Chlorobenzamido]ethyl)-phenoxy]-2-methylpropanoic acid, ANW-42342, BG0107, CCG-39683, NSC758174, s4159, AKOS005107743, Tox21_110645_1, AB03023, AC-6817, AN-9653, API0001705, BCP9000398, CS-2874, DB01393, HS-0040, LP00500, MCULE-9775992840, NSC-758174, SB17361, VA10400, IDI1_000092, IDI1_033784, NCGC00016850-02, NCGC00016850-03, NCGC00016850-04, NCGC00016850-05, NCGC00016850-06, NCGC00016850-07, NCGC00016850-08, NCGC00016850-09, NCGC00016850-10, NCGC00016850-11, NCGC00016850-12, NCGC00016850-15, NCGC00023317-03, NCGC00023317-04, NCGC00023317-05, NCGC00023317-06, NCGC00023317-07, NCGC00023317-08, NCGC00255376-01, NCGC00261185-01, 4CA-0271, Bezafibrate, analytical reference material, SC-04393, BCP0726000153, SBI-0051715.P002, AB1004588, AX8116634, LS-124535, TR-016482, 2-(4-(2-(4-chlorobenzamido)ethyl)phenoxy), AB00052265, B3346, FT-0622617, ST51014927, SW196871-4, D01366, K-8763, AB00052265-15, AB00052265_16, AB00052265_17, 859B670, I06-1311, SR-01000000106-3, SR-01000000106-4, SR-01000000106-5, BRD-K46018455-001-06-0, BRD-K46018455-001-17-7, SR-01000000106-10, Bezafibrate, European Pharmacopoeia (EP) Reference Standard, 2-(4-(2-((4-CHLOROBENZOYL)AMINO)ETHYL)PHENOXY)-2-M, 2-(4-(2-parachlorobenzamidoethyl)phenoxy)-2-methylpropionic acid, 2-[4-(2-[4-Chlorobenzamido]ethyl)- phenoxy]-2-methylpropanoic acid, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl propanoic acid, 2-(4-{2-[(4-chlorophenyl)carbonylamino]ethyl}phenoxy)-2-methylpropanoic acid, 2-[4-(2-{[(4-chlorophenyl)carbonyl]amino}ethyl)phenoxy]-2-methylpropanoic acid, BF; 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl propanoic acid, Befibrat, Bezafisal, benzafibrate, benzofibrate, Beza Lande, Beza Puren, BezaLande, BezaPuren, PB, Bezafibrat, Bezalip (TN), Bezafibrate TAD Brand, Bezafibrate Isis Brand, Bezafibrate Teva Brand, Bezafibrate Bayer Brand, Bezafibrate Elfar Brand, Bezafibrate Hexal Brand, Bezafibrate Roche Brand, -2-methylpropanoic acid, Bezafibrate Hennig Brand, Bezafibrate Merckle Brand, TAD Brand of Bezafibrate, Isis Brand of Bezafibrate, Teva Brand of Bezafibrate, Bezafibrate Lakeside Brand, Bayer Brand of Bezafibrate, Bezafibrate Azupharma Brand, Bezafibrate Betapharm Brand, D00WCX, Elfar Brand of Bezafibrate, Hexal Brand of Bezafibrate, Roche Brand of Bezafibrate, Hennig Brand of Bezafibrate, Bezafibrate Cryopharma Brand, Bezafibrate Synthelabo Brand, Merckle Brand of Bezafibrate, Lakeside Brand of Bezafibrate, Azupharma Brand of Bezafibrate, Betapharm Brand of Bezafibrate, Bezafibrate Berlin-Chemie Brand, Cryopharma Brand of Bezafibrate, Synthelabo Brand of Bezafibrate, Bezafibrate, 98% - 5G 5g, Bezafibrate (JP15/USAN/INN), C19-H20-Cl-N-O4, Berlin Chemie Brand of Bezafibrate, Berlin-Chemie Brand of Bezafibrate, CID39042, BM15.075, CS-O-00952, Boehringer Mannheim Brand of Bezafibrate, B1680, A16307, D001629, 2-[p-[2-(p-chlorobenzamido)ethyl]phenoxy]-2-methylpropionic acid, 63927-29-7, BF,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited